Meta-Analysis the Effect of Oral Combination Contraceptive on Hypertension and Stroke
DOI:
https://doi.org/10.26911/thejmch.2022.07.05.03Abstract
Background: Combined oral contraceptives are a form of contraception that are considered safe and effective for some women, but this does not rule out the possibility that combined oral contraceptives contribute to adverse health effects. Several epidemiological studies have shown that oral contraceptives have adverse effects on women's health. The use of contraceptive pills containing the hormones estrogen and progesterone can cause an increase in blood pressure and also stroke if used continuously. The purpose of this study was to estimate the magnitude of the risk of using combined oral contraceptives on the incidence of hypertension and stroke with a meta-analysis study.
Subjects and Method: This research is a systematic review and meta-analysis using PRISMA flowchart diagram guidelines. The article search process was carried out between 2007-2022 using 3 databases, including Google Scholar, PubMed, and Science Direct. The keywords used in the database search were
References
Baziad A (2014). Kontrasepsi hormonal edisi kedua (Hormonal contraceptives second edition). Jakarta: PT Bina Pustaka Sarwono Prawirohardjo.
BKKBN (2015). Rencana strategis badan kependudukan dan keluarga berencana nasional (National population and family planning agency strategic plan). 1
CEBMa. (2014). Critical Appraisal for Case Control. Amsterdam.
Chen C, Li Y, Chen F, Pan H, Shen H, Sun Z, Wu Y, et al. (2010). Estrogen receptor beta genetic variants and combined oral contraceptive use as relates to the risk of hypertension in Chinese women. Arc Med Res. 41(8): 599
Gatiningsih, Sutrisno E. (2017). Kependudukan dan ketenagakerjaan (Population and employment). In Modul Mata Kuliah.
Johnson W, Onuma O, Owolabi M, Sachdev, S (2016). Stroke: a global response is needed. Bull World Health Organ, 94(9): 634A-635A. DOI: 10.2471/BLT.16.181636.
Kemenkes RI (2014). Pusdatin Hipertensi (Hypertension Center). Infodatin, Hipertensi, 1
Kemenkes RI (2021). Profil kesehatan indonesia tahun 2020. Jakarta : Kemenkes RI
Maitre SC (2013). History of oral contraceptive drugs and their use worldwide. Best Pract Res: Clin Endocrinol Metab, 27(1): 3
Pangaribuan L, Lolong DB (2015). Hubungan penggunaan kontrasepsi pil dengan kejadian hipertensi pada wanita usia 15-49 tahun di Indonesia tahun 2013 (The relationship between the use of oral contraceptives and the incidence of hypertension in women
aged 15-49 years in Indonesia in 2013). Media Penelitian dan Pengembangan Kesehatan, 25(2): 1
Park H, Kim K (2013). Associations between oral contraceptive use and risks of hypertension and prehypertension in a cross-sectional study of korean women. BMC Women
Pezzini A, Grassi M, Lacoviello L, Zotto ED, Archetti S, Giossi A, Padovani A (2007). Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptives. J Neurol, Neurosurg and Psychiatry, 78(3): 271
1136/jnnp.2006.101675.
Rotermann M, Dunn S, Black A (2015). Oral contraceptive use among women aged 15 to 49: results from the canadian health measures survey. Health Reports, 26(10): 21
Wang C, Li Y, Bai J, Qian W, Zhou J, Sun Z, Ba L, et al. (2012) Increased risk of stroke in oral contraceptive users carried replicated genetic variants: a population-based case-control study in China. Hum Genet, 131(8): 1337
Wang C, Li Y, Bai J, Qian W, Zhou J, Sun Z, Ba L, et al. (2011). General and central obesity, combined oral contraceptive use and hypertension in chinese women. Am J Hypertens, 24(12): 1324
Wei W, Li Y, Chen F, Chen C, Sun T, Sun Z, Wu Y, et al. (2011). Dyslipidaemia, combined oral contraceptives use and their interaction on the risk of hypertension in Chinese women. J Hum Hypertens, 25(6): 364
WHO (2018). Noncommunicable Disease : Country Profile 2018.
Xu Z, Li Y, Huang X, Shen W, Bai J, Shen C, Zhao Y (2017). ESR2 genetic variants and combined oral contraceptive use associated with the risk of stroke. Arch Med Res, 48(2): 203
